S. 548

119th Congress

In Committee

Caribbean Border Counternarcotics Strategy Act

Sponsored byRepublican:Sen. Scott, Rick [R-FL]FL· Introduced 12 February 2025

1

Cosponsors

2

Actions

0

Amendments

0

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Read twice and referred to the Committee on the Judiciary.

12 February 2025·1 year ago

Summary

Introduced in Senate · Updated 1 April 2026

Caribbean Border Counternarcotics Strategy Act

This bill provides statutory authority for the requirement for the Office of National Drug Control Policy (ONDCP) to include a Caribbean Border Counternarcotics Strategy in its National Drug Control Strategy. This strategy must include measures for preventing the illegal trafficking of drugs through the Caribbean region into the United States, including measures to combat drug trafficking and drug-related violent crime in Puerto Rico and the U.S. Virgin Islands.

The bill also revises ONDCP's authorization to (1) add definitions for state and for United States to specify that its authorization includes U.S. territories and possessions, and (2) revise the definition for supply reduction to ensure that the National Drug Control Strategy includes efforts to disrupt the financial networks of drug trafficking organizations.

Timeline

2 actions

  1. Read twice and referred to the Committee on the Judiciary.

    12 February 2025 · IntroReferral

  2. Introduced in Senate

    12 February 2025 · IntroReferral

Sponsorship

1 cosponsors

Sponsor

Republican:Sen. Scott, Rick [R-FL]FL

Cosponsors

  • Democrat1100%

Classification

Policy area

Crime and Law Enforcement

Legislative subjects

Border security and unlawful immigrationCaribbean areaCrime preventionDrug trafficking and controlled substancesPuerto RicoSmuggling and traffickingU.S. territories and protectoratesVirgin Islands
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.